» Articles » PMID: 39518648

Sequelae of Acute Pulmonary Embolism: From Post-Pulmonary Embolism Functional Impairment to Chronic Thromboembolic Disease

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Nov 9
PMID 39518648
Authors
Affiliations
Soon will be listed here.
Abstract

Among survivors of acute pulmonary embolism (PE), roughly half report persistent dyspnea, impaired functional status, and decreased quality of life. Post-pulmonary embolism syndrome (PPES) is a broad condition which has been increasingly recognized in recent years and may be due to post-pulmonary embolism functional impairment, chronic thromboembolic disease, or the most severe long-term complication of PE, chronic thromboembolic pulmonary hypertension. Despite guideline recommendations for appropriate follow-up for post-pulmonary embolism patients, PPES remains underrecognized and diagnostic testing underutilized. Patients with symptoms suggestive of PPES at follow-up should undergo a transthoracic echocardiogram to screen for the presence of pulmonary hypertension; additional testing, such as a ventilation/perfusion scan, right heart catheterization, and cardiopulmonary exercise testing may be indicated. The pathophysiology of post-pulmonary embolism syndrome is complex and heterogeneous. In chronic thromboembolic pulmonary hypertension, the pathophysiology reflects persistent pulmonary arterial thrombi and a progressive small vessel vasculopathy. In patients with chronic thromboembolic disease or chronic thromboembolic pulmonary hypertension, medical therapy, balloon pulmonary angioplasty, or pulmonary thromboendarterectomy should be considered, and in cases of chronic thromboembolic pulmonary hypertension, pulmonary thromboendarterectomy significantly improves mortality. In all causes of post-pulmonary embolism syndrome, rehabilitation is a safe treatment option that may improve quality of life.

References
1.
Jevnikar M, Solinas S, Brenot P, Lechartier B, Kularatne M, Montani D . Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept. Eur Respir J. 2023; 62(5). DOI: 10.1183/13993003.00517-2023. View

2.
Jais X, Brenot P, Bouvaist H, Jevnikar M, Canuet M, Chabanne C . Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med. 2022; 10(10):961-971. DOI: 10.1016/S2213-2600(22)00214-4. View

3.
Chang H, Chang W, Chen P, Lin C, Hsu C . Pulmonary thromboembolism with computed tomography defined chronic thrombus is associated with higher mortality. Pulm Circ. 2020; 10(2):2045894020905510. PMC: 7222268. DOI: 10.1177/2045894020905510. View

4.
Lankeit M, Krieg V, Hobohm L, Kolmel S, Liebetrau C, Konstantinides S . Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2017; . DOI: 10.1016/j.healun.2017.06.011. View

5.
Bashir R, Noory A, Oliveros E, Romero C, Maruthi R, Mirza A . Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Initial Results of U.S. Regional Program. JACC Adv. 2023; 2(3). PMC: 10373249. DOI: 10.1016/j.jacadv.2023.100291. View